
Cavendish Bio
卡文迪许生物
Cavendish Bio
Biotech/Healthcare
Cavendish Bio is an innovative drug developer dedicated to the R&D of novel drug technologies, MAH (Marketing Authorization Holder) manufacturing, and academic promotion services for its developed drugs. Key development areas include anti-tumor drugs (hematologic diseases), diabetes drugs…
Latest round: Series A (2026)
Source: ChinaBulls — chinabulls.com
Last updated 2026-10-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.